Keryx Biopharmaceuticals (KERX)
Create an AlertKeryx Biopharmaceuticals Market Cap:
630.86M for June 18, 2013Keryx Biopharmaceuticals Historical Market Cap Data
Pro Data ExportThere is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| June 18, 2013 | 630.86M |
| June 17, 2013 | 617.79M |
| June 14, 2013 | 596.62M |
| June 13, 2013 | 569.58M |
| June 12, 2013 | 570.39M |
| June 11, 2013 | 600.46M |
| June 10, 2013 | 632.50M |
| June 7, 2013 | 625.14M |
| June 6, 2013 | 625.14M |
| June 5, 2013 | 606.35M |
| June 4, 2013 | 626.78M |
| June 3, 2013 | 642.30M |
| May 31, 2013 | 654.56M |
| May 30, 2013 | 666.82M |
| May 29, 2013 | 665.19M |
| May 28, 2013 | 653.74M |
| May 24, 2013 | 656.20M |
| May 23, 2013 | 656.20M |
| May 22, 2013 | 643.94M |
| May 21, 2013 | 657.83M |
| May 20, 2013 | 648.84M |
| May 17, 2013 | 657.01M |
| May 16, 2013 | 653.74M |
| May 15, 2013 | 669.27M |
| May 14, 2013 | 692.15M |
| May 13, 2013 | 715.03M |
| May 10, 2013 | 671.72M |
| May 9, 2013 | 639.85M |
| May 8, 2013 | 641.49M |
| May 7, 2013 | 652.93M |
| May 6, 2013 | 674.17M |
| May 3, 2013 | 658.65M |
| May 2, 2013 | 645.57M |
| May 1, 2013 | 638.14M |
| April 30, 2013 | 666.00M |
| April 29, 2013 | 670.09M |
| April 26, 2013 | 666.00M |
| April 25, 2013 | 681.53M |
| April 24, 2013 | 661.92M |
| April 23, 2013 | 679.08M |
| April 22, 2013 | 679.89M |
| April 19, 2013 | 656.20M |
| April 18, 2013 | 621.87M |
| April 17, 2013 | 632.50M |
| April 16, 2013 | 641.49M |
| April 15, 2013 | 630.86M |
| April 12, 2013 | 657.83M |
| April 11, 2013 | 661.92M |
| April 10, 2013 | 676.63M |
| April 9, 2013 | 661.92M |
About Market Capitalization
Market Capitalization (Market Cap) is a measurement of business value based on share price and number of shares outstanding. It generally represents the market's view of a company's stock value and is a determining factor in stock valuation.
For example, if a company has 1.5 million shares outstanding at a share price of $25, its market cap is $37.5 million (1.5 million x $25). Companies can be categorized based upon the size of their market capitalization.
There are five basic groups: mega-cap (market cap over $200B), large-cap ($10B–$200B), mid-cap ($2B–$10B), small-cap ($300M–$2B), and micro-cap ($50M-$300M). Market cap is not always an accurate indication of value because it does not account for debt and other factors.
Learn More
KERX Market Cap Benchmarks
| Companies | |
|---|---|
| ACADIA Pharmaceuticals | 1.469B |
| Supernus Pharmaceuticals | 208.53M |
| Amarin Corporation | 995.07M |
KERX Market Cap Rankings
| Overall |
78th percentile 3574 of 16770 |
| Sector |
80th percentile 276 of 1408 in Healthcare |
| Industry |
79th percentile 31 of 152 in Drug Manufacturers - Specialty & Generic |
KERX Market Cap Range, Past 5 Years
| Minimum | 4.762M | Mar 5 2009 |
| Maximum | 715.03M | May 13 2013 |
| Average | 200.44M |
